Skip to main content

Peer Review reports

From: Chemotherapy re-use versus anti-angiogenic monotherapy as the third-line treatment of patients with metastatic colorectal cancer: a real-world cohort study

Original Submission
15 Jul 2023 Submitted Original manuscript
8 Oct 2023 Reviewed Reviewer Report
13 Oct 2023 Reviewed Reviewer Report - Eleonora Lai
28 Oct 2023 Reviewed Reviewer Report
9 Nov 2023 Author responded Author comments - Ting Deng
Resubmission - Version 2
9 Nov 2023 Submitted Manuscript version 2
12 Nov 2023 Author responded Author comments - Ting Deng
Resubmission - Version 3
12 Nov 2023 Submitted Manuscript version 3
23 Dec 2023 Reviewed Reviewer Report - Eleonora Lai
12 Jan 2024 Reviewed Reviewer Report
18 Jan 2024 Author responded Author comments - Ting Deng
Resubmission - Version 4
18 Jan 2024 Submitted Manuscript version 4
2 Feb 2024 Author responded Author comments - Ting Deng
Resubmission - Version 5
2 Feb 2024 Submitted Manuscript version 5
15 Feb 2024 Author responded Author comments - Ting Deng
Resubmission - Version 6
15 Feb 2024 Submitted Manuscript version 6
26 Feb 2024 Reviewed Reviewer Report
28 Feb 2024 Reviewed Reviewer Report - Eleonora Lai
Resubmission - Version 7
Submitted Manuscript version 7
Publishing
29 Feb 2024 Editorially accepted
5 Mar 2024 Article published 10.1186/s12885-024-12072-5

You can find further information about peer review here.

Back to article page